Avalo Therapeutics (AVTX) Net Margin (QoQ) (2016 - 2024)
Avalo Therapeutics (AVTX) Net Margin (QoQ) (2016 - 2024) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.77 Mn |
| Dec 31, 2023 | 78,478.00 |
| Sep 30, 2023 | -94,107.00 |
| Jun 30, 2023 | 82,161.00 |
| Dec 31, 2021 | -3,531.00 |
| Sep 30, 2021 | 357.00 |
| Jun 30, 2021 | 2,447.00 |
| Mar 31, 2021 | -5,574.00 |
| Dec 31, 2020 | 5,116.00 |
| Sep 30, 2020 | 1,618.00 |
| Jun 30, 2020 | -7,170.00 |
| Mar 31, 2020 | -14,558.00 |
| Dec 31, 2019 | 23,261.00 |
| Sep 30, 2019 | 21,344.00 |
| Jun 30, 2019 | -17,383.00 |
| Mar 31, 2019 | -10,131.00 |
| Dec 31, 2018 | 61,612.00 |
| Sep 30, 2018 | -47,822.00 |
| Jun 30, 2018 | -3,893.00 |
| Mar 31, 2018 | 7,516.00 |